Intraoral perfusion assessment using endoscopic hyperspectral imaging (EHSI)– first description of a novel approach
Clinical Oral Investigations · 2025
DOI: 10.1007/s00784-025-06197-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oral Investigations, 2025. Verfasst von Paul Römer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany. Hauptthemen laut MEDLINE: Mouth Mucosa, Hyperspectral Imaging, Endoscopy, Ischemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin der Johannes Gutenberg-Universität Mainz.
Abstract (Originalsprache)
Objectives
This study aimed to establish a method to detect and quantify mucosal malperfusion intraorally using state-of-the-art Endoscopic Hyperspectral Imaging (EHSI). For this purpose, mucosal ischemia was selectively induced by intraligamentary anesthesia (ILA) with and without + epinephrine using a standardized protocol. Materials and methods EHSI was performed using a novel endoscopic hyperspectral imaging system. Parameters assessed were Tissue Oxygen Saturation (StO 2 [%]), Tissue Hemoglobin Index (THI), Near Infrared Perfusion Index (NPI) and Tissue Water Index (TWI). Fifty-seven healthy subjects received ILA using Articaine 4% with (ILA+) and without (ILA-) epinephrine at a dosage of 1:200,000 administered mesially and distally to the target tooth 42 (Universal No. 26). Mucosal perfusion was assessed using EHSI for 45 min post-injection.
Results
After ILA+, a distinct ischemia of the mucosa was already clinically apparent after 30 s with significant reduction of THI and StO 2 by an average of 57% ( p < 0.001) and 7% ( p < 0.040) compared to baseline values. Persistent hypoperfusion of the oral mucosa was observed throughout the monitoring period, exhibiting a gradual resolution at the 30-minute mark, and nearing baseline perfusion approximately 45 min post-injection. There was no papillary necrosis after ILA + injection.
Conclusion
EHSI is suitable to adequately detect and visualize actual perfusion of the intraoral mucosa. The study revealed that LA with epinephrine (1:200,000) induce temporary hypoxia in the dental papilla but without causing severe ischemia. Clinical relevance EHSI will enable promising applications in the future, i.a. success monitoring of periodontal therapies, intraoral free flap monitoring and the assessment of cancer margins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany.
- Department of Oral and Maxillofacial Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany. daniel.thiem@unimedizin-mainz.de.
Förderung
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Zitieren
APA
Römer, P., Blatt, S., Siegberg, F., Vinayahalingam, S., Al-Nawas, B., Kämmerer, P. W., & Thiem, D. G. E. (2025). Intraoral perfusion assessment using endoscopic hyperspectral imaging (EHSI)– first description of a novel approach. Clinical Oral Investigations. https://doi.org/10.1007/s00784-025-06197-5
Vancouver
Römer P, Blatt S, Siegberg F, Vinayahalingam S, Al-Nawas B, Kämmerer PW, et al. Intraoral perfusion assessment using endoscopic hyperspectral imaging (EHSI)– first description of a novel approach. Clinical Oral Investigations. 2025. doi:10.1007/s00784-025-06197-5
BibTeX
@article{Rmer2025,
author = {Römer, Paul and Blatt, Sebastian and Siegberg, Fabia and Vinayahalingam, Shankeeth and Al-Nawas, Bilal and Kämmerer, P W and Thiem, Daniel G E},
title = {Intraoral perfusion assessment using endoscopic hyperspectral imaging (EHSI)– first description of a novel approach},
journal = {Clinical Oral Investigations},
year = {2025},
doi = {10.1007/s00784-025-06197-5}
}
EUVIMED